Amyloidosis is a complex disease and the program at Huntsman Cancer Institute (HCI) uses a collaborative approach to provide comprehensive medical care. Researchers are tirelessly trying to find new ...

Managing Alzheimer’s disease requires an intricate understanding of available treatments. Michelle Sorweid, DO, MPH, sheds light on anti-amyloid antibody therapy, how it works, and what patients are ...

In AL amyloidosis, abnormal plasma cells in the bone marrow produce misfolded proteins that clump together clump together ...

This transcript has been edited for clarity. Michelle M. Kittleson, MD: Welcome to Medscape InDiscussion: Heart Failure. I'm your host, Dr Michelle Kittleson. This is the seventh episode of our ...

Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a reminder that understanding your heart, ...

The data on the kappa AL amyloidosis group treated with anselamimab was presented by AstraZeneca at ASCO 2026.

It can be tough to share the news of a genetic health condition, but doing so empowers your relatives to take charge of their health. ATTR occurs when the protein transthyretin (TTR), which is made in ...

Isabelle Lousada was in her early 30s when she collapsed at her Philadelphia wedding in 1995. A London architect, she had suffered a decade of mysterious symptoms: tingling fingers, swollen ankles, a ...

While still considered a rare disease, transthyretin amyloid cardiomyopathy (ATTR-CM) is nevertheless emerging in more people than previously thought due to increased interest and improved access to ...

Are anti-amyloid drugs as effective against Alzheimer’s disease as experts had hoped? Image credit: smodj/Getty Images Some of these medications include anti-amyloid drugs, which work to remove ...

AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced that ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein called amyloid-β was responsible for memory loss in Alzheimer’s disease. On its ...